Home Industry Reports Custom Research Blogs About Us Contact us

Psoriasis Treatment Market Share

Report ID: FBI 2275

|

Published Date: Mar-2024

|

Format : PDF, Excel

Segmentation Analysis:

Biologics:

Biologics are a type of treatment that target the immune system to reduce inflammation and slow down the rapid growth of skin cells associated with psoriasis. This sub-segment includes drugs like adalimumab, etanercept, and ustekinumab, which are widely used for moderate to severe psoriasis. Biologics are often preferred by patients who have not responded well to other treatments or have severe psoriasis that affects a large area of their body.

Topical Treatments:

Topical treatments are applied directly to the skin and are often used for mild to moderate cases of psoriasis. This sub-segment includes products such as corticosteroids, vitamin D analogs, and retinoids. These treatments help to reduce inflammation, itchiness, and scaling associated with psoriasis. They are often the first line of treatment for individuals with psoriasis affecting a small area of their body.

Get more details on this report -

Competitive Landscape:

The competitive landscape of the psoriasis treatment market is characterized by the presence of several key players who are focused on the development of innovative and effective treatment options for patients. Some of the prominent companies in the market include AbbVie Inc., Amgen Inc., Johnson & Johnson, Novartis AG, and Pfizer Inc. These companies are actively engaged in research and development activities to introduce novel therapies for the management of psoriasis.

Furthermore, collaborations, partnerships, and strategic acquisitions are common strategies adopted by these market players to expand their product offerings and strengthen their position in the market. For instance, Novartis AG acquired the rights to tildrakizumab, a biologic treatment for psoriasis, from Almirall, S.A. in order to enhance its psoriasis treatment portfolio. Such strategic initiatives contribute to the overall growth and competitiveness of the psoriasis treatment market.

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Psoriasis Treatment Market Size & Share, By Drug C...

RD Code : 24